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Abstract
PGE2 has been implicated in abdominal aortic aneurysm (AAA) associated hypervasculari-
zation. PGE2-metabolism involves 15-hydroxyprostaglandin-dehydrogenase (15-PGDH)
the expression of which in AAA is unknown. The aim of this study was to examine the
expression and cell distribution of 15-PGDH in AAA. Here, we show that 15-PGDH mRNA
levels were significantly higher in aorta samples from patients undergoing AAA repair than
in those from healthy multiorgan donors. Consequently, the ratio of metabolized PGE2
secreted by aortic samples was significantly higher in AAA. AAA production of total PGE2
and PGE2 metabolites correlated positively with PGI2 production, while the percentage of
metabolized PGE2 correlated negatively with the total amount of PGE2 and with PGI2. Tran-
script levels of 15-PGDH were statistically associated with leukocyte markers but did not
correlate with microvascular endothelial cell markers. Immunohistochemistry revealed 15-
PGDH in the areas of leukocyte infiltration in AAA samples, mainly associated with CD45-
positive cells, but not in normal aorta samples. We provide new data concerning 15-PGDH
expression in human AAA, showing that 15-PGDH is upregulated in AAA and mainly
expressed in infiltrating leukocytes. Our data suggest that microvasculature was not
involved in PGE2 catabolism, reinforcing the potential role of microvasculature derived
PGE2 in AAA-associated hypervascularization.
Introduction
Abdominal aortic aneurysm (AAA) is a vascular degenerative disease with high morbidity and
mortality in the aged population in industrialized countries and mortality rates associated with
rupture of AAA are high [1]. AAA formation and rupture are closely accompanied by inflam-
mation and neovascularization of the media layer both contributing to the progressive
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weakening and dilation of the vascular wall [2]. Prostaglandin (PG) E2 a prevalent inflamma-
tory mediator in many tissues and inflammatory diseases has been involved in angiogenic pro-
cesses in cancer and other pathologies.
Animal models and human studies indicate that PGE2 is involved in the pathogenesis of AAA
[3–5]. PGE2 binds to four distinct E-prostanoid receptors (EP1–4) that belong to the family of
seven transmembrane G protein-coupled receptors [6]. Biosynthesis of PGE2 begins with the
release of arachidonic acid by phospholipases from the membrane phosphoglycerides, which is
in turn oxidized to PGH2 by the action of cyclooxygenase (COX) [7,8]. PGH2 isomerizes to PGE2
by PGE-synthases (PGES). The microsomal isoform of PGES (mPGES-1) is inducible by proin-
flammatory cytokines and seems to be the main isoenzyme involved in PGE2 biosynthesis under
inflammatory conditions [9–12]. COX-2/mPGES-1 is widely regarded as the major contributing
enzymatic chain for PGE2 biosynthesis under pathological conditions.
Despite the relevance of angiogenesis in AAA, information concerning COX-2/mPGES-1
derived PGE2 in the AAA-associated hypervascularization is limited and restricted to leuko-
cytes COX-2-derived PGE2 [3,13–15]. We recently reported data supporting the role of micro-
vascular endothelial cells (MVEC) COX-2/mPGES-1/EP-4 axis on the AAA associated
hypervascularization [16]. We confirmed previous reports showing that COX-2 is upregulated
in AAA and we found that mPGES-1 expression was also increased in AAA [16]. Both COX-2
and mPGES-1 have been found to be expressed in MVEC, VSMC and infiltrating leukocytes in
AAA [10,11,16,17]. Nevertheless, the relative contribution of vascular cells versus infiltrating
leukocytes to the pool of active PGE2 in AAA remains unclear. Regarding PGE2-mediated
angiogenesis, the relative cell contribution to the active pool of this PG and the expression pro-
file of PGE-receptors is relevant to understand the role of MVEC in AAA development.
Levels of PGE2 are regulated by its biosynthesis to degradation ratio. The first enzyme involved
in PG catabolism is NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH). PGs are
rapidly metabolized by the initial oxidation of the 15(S)-hydroxyl group catalyzed by 15-PGDH
followed by the reduction of the 13,14-double bond generating 13,14-dihydro-15-oxo-prostaglan-
dins [18]. This enzyme has therefore been considered key to the biological inactivation of prosta-
glandins. 15-PGDH is widely distributed in various mammalian tissues, lung being one of the
most active [19], and it has been viewed as a tumor suppressor in the field of cancer [20,21]. Nev-
ertheless, its role in cardiovascular diseases, particularly in AAA, is unknown. The present study
was undertaken to compare 15-PGDH expression in samples of aorta from AAA patients and
healthy donors and to determine its cellular localization.
Materials and Methods
Patients
The study was approved by the Comité Ético de Investigación Clínica del Hospital Santa Creu i
Sant Pau, approval number 10/009/1048. Written informed consent was obtained from each
patient. The study conformed to the principles outlined in the Declaration of Helsinki. The
inclusion criteria for this study were patients who underwent open repair for AAA with an ath-
erosclerotic aneurysm and in whom an infrarenal aorta biopsy was taken during the interven-
tion. The exclusion criteria were inadequate or no aortic biopsy, pseudoaneurysms, and
infectious or inflammatory aneurysms. All patients underwent surgery at Hospital de la Santa
Creu i Sant Pau (HSCSP).
Tissue samples
Samples were obtained from the remaining mid-infrarenal aortic wall after exclusion and pros-
thetic replacement of AAA. Normal aortas (NA) were obtained from healthy aorta from
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multiorgan donors and samples were also taken from the mid-portion of the infrarenal abdom-
inal aorta at organ harvest. When a luminal thrombus was present it was separated before the
aorta biopsy was taken and aortic tissue was washed twice with cold phosphate buffered saline
(PBS). A portion of each sample was placed in RNAlater solution (Qiagen GmbH, Hilden, Ger-
many) and stored at 4°C for 24 hours before long-term storage at −80°C until further process-
ing for RNA isolation. When possible a portion was fixed in formalin solution 10% (Sigma-
Aldrich, Inc St Louis, MO) for 24 h and included in paraffin for immunohistochemical studies.
Clinical data definitions
Risk factor definitions used in this study were: diabetes mellitus: glycated haemoglobin
>5.8% or use of oral antidiabetic drugs or insulin; arterial hypertension: systolic blood pressure
140 mm Hg, diastolic blood pressure 80 mmHg or use of antihypertensive medication;
hyperlipidemia: a total cholesterol>6.2 mmol/L, LDL cholesterol>1.70 mmol/L or triglycer-
ides>1.65 mmol/L; smokers: current smokers and ex-smokers stopped smoking<1 year;
chronic occlusive pulmonary disease (COPD): FEV1/FVC<0.7; and renal insufficiency: esti-
mated glomerular filtration rate (eGFR)60 mL/min/1.73 m2 calculated using the Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [22].
Microvascular endothelial cells (MVEC) culture
MVEC were isolated from human adult foreskins using a previously described technique
[17,23]. In brief, foreskins obtained from adult circumcisions were placed in PBS supplemented
with penicillin 200 units/mL, streptomycin 200 μg/mL and amphotericin B 0.5 μg/mL (all from
Biological Industries, Kibbutz Beit Haemek, Israel). Foreskins were cut into 3 mm squares and
placed in PBS containing 0.3% trypsin and 1% EDTA at 37°C for 30 minutes. Segments were
then washed several times with PBS, placed in a Petri dish in M199 containing 10% foetal
bovine serum (FBS), and individually compressed with the side of a scalpel blade to express
microvascular fragments. The microvascular segments were passed through a 150 μm stainless
steel mesh and collected by centrifugation at 300xg for 15 minutes. MVEC were seeded on
a gelatin-coated cell culture flask and cultured in mediumMCDB131 with 20% FBS; L-gluta-
mine 2 mmol/L, penicillin 200 units/mL, streptomycin 200 μg/ml, EGF 20 ng/mL and bFGF
5 ng/mL (all from Biological Industries). When cells reached confluence, they were purified
with Dynabeads CD31 (Dynabeads, Invitrogen Dynal ASA, Oslo, Norway) following the man-
ufacturer’s instructions. Flow cytometry and positive staining for CD31, platelet endothelial
cell adhesion molecule-1 (PECAM-1) confirmed the purity of the cell population. MVEC were
used in passage 3
Aortic VSMC culture
Aortic human VSMC cultures were established by an explant procedure from multi-organic
donor aortas as previously described [10,11]. The artery was longitudinally split and the endo-
thelium was removed by gently scraping. The tissue was minced and allowed to adhere to the
culture flask by incubation in a small amount of DMEM containing 10% FBS. VSMC were
characterized by α-actin positive staining.
Analysis of mRNA levels in the tissues and culture cells
Tissues were homogenized in the FastPrep-24 homogenizer and Lysing Matrix D tubes (MP
Biomedicals, Solon, OH). RNA was extracted using Trizol (Invitrogen, Carlsbad, CA), follow-
ing the manufacturer's instructions. The total RNA from cell cultures was extracted using
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Ultraspec (Biotecx Laboratories, Inc., Houston, TX, USA) according to the manufacturer’s
instructions. cDNA was prepared by reverse transcription of 1 μg RNA using the High-Capac-
ity cDNA Archive kit with random hexamers (Applied Biosystems, Foster City, CA). mRNA
expression of the selected genes was studied by real-time PCR in an ABI Prism 7900HT using
pre-designed validated assays (TaqMan Gene Expression Assays; Applied Biosystems) and uni-
versal thermal cycling parameters. Relative expression was expressed as transcript/β-actin
ratios.
Analysis of prostanoids in the Tissue-conditioned media
Tissue-conditioned media were obtained from approximately 150 mg of NA and AAA aorta
fragments by incubating the tissues in 1 mL serum-free DMEM (Biological Industries,) in a cell
incubator for 48 hours. The medium was then recovered and kept at -80°C until analysis.
Released PGE2 and 6-oxo-PGF1α (the stable metabolite of PGI2), were analyzed by EIA (Cay-
man Chemical, Ann Arbor, MI) following the manufacturer’s instructions. To evaluate levels
of PGE2 metabolites (MPGE2) we used an enzyme immunoassay (EIA) kit that converts
13,14-hihydro-15-oxo metabolites of PGE2 into a single stable derivative (Cayman Chemical)
following manufacturer’s instructions.
Immunohistochemistry
Immunohistochemical studies were performed using a rabbit polyclonal antibody against
15-PGDH (diluted 1:150) from Cayman Chemical. Three-micrometer sections of paraffin-
embedded tissue samples were stained in a Dako Autostainer Link 48 using the Dako EnVision
Flex Kit. Diaminobenzidine was used as chromogen.
Double-fluorescence immunostaining
For antigen co-localization studies, double-fluorescence immunostaining was performed using
a sequential method. After deparaffinization and antigen retrieval, blocking for non-specific
binding was performed at 4°C overnight. Appropriate concentrations of antibodies were then
sequentially applied for 1 hour at room temperature, with PBS washing after each incubation.
Slides were first incubated with anti-CD45, anti-CD68, CD20 or CD3 (IR751, IR7613, IR604
and IR503 without further dilution, Dako), followed by incubation with Alexa Fluor 594 goat-
antimouse IgG (diluted 1/200; Life Technologies). Next, slides were incubated with the anti-
15-PGDH antibody followed by incubation with Alexa Fluor 488 goat-antirabbit IgG (diluted
1/200; Life Technologies). As a negative control, sections were incubated omitting primary
antibodies. Samples were then mounted with ProLong Gold antifade reagent with DAPI
(Molecular Probes, Life Technologies Co, Eugene, OR). Images were obtained using an SP5
Leica confocal microscope.
Statistical analysis
Sigma-Plot software was used for statistical analysis. All data regarding transcript levels are
expressed relative to β-actin x1000. All quantitative data in this study were non-normally dis-
tributed. We used the Mann-Whitney Rank Sum Test to compare the two groups. The Pearson
Product Moment Correlation was used to evaluate the association between continuous vari-
ables after Log10 transformation of data with non-normal distribution. A "P" value below 0.05
was considered significant.
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Results
Table 1 summarizes the characteristics of patients and donors included in this study. We ana-
lized the expression of 15-PGDH, COX-2 and mPGES-1 in AAA samples with NA by quantita-
tive RT-PCR. The expression levels of any RNA transcripts did not fit a normal distribution.
Results in Fig 1A show that, as expected [16], COX-2 and mPGES-1 expression was increased
in AAA samples and that 15-PGDHmRNA was also significantly higher in AAA than in NA
samples. Results regarding 15-PGDH were consistent with a significantly high ratio of metabo-
lized PGE2 respect to total PGE2 in the tissue-conditioned media from AAA tissue samples
than in NA (Fig 1B). As gender composition was different in AAA and NA populations, we
tested for differences in the levels of 15-PGDH between males and females in the NA group
(AAA group was 100% males) but found no statistically significant difference between genders
Attempting to ascertain if PGE2 degradation occurs in AAAmicrovessels, we determined
the correlation between mRNA levels of 15-PGDH and those of MVEC and leukocyte markers.
We analyzed the expression of the von Willebrand factor (vWF) and the endothelial nitric
oxide synthase (eNOS) as endothelial cell markers and CD45 and CD68 as leukocyte markers.
Cell markers analyzed were significantly enhanced in AAA samples (Fig 2A). Correlations
between 15-PGDH and MVEC markers were not significant (Fig 2B), but 15-PGDH transcript
levels were significantly associated with both leukocyte markers. The correlation of 15-PGDH
with the macrophage marker CD68 was less significant than with the pan-leukocyte marker
CD45 (Fig 2C).
Table 1. Clinical characteristics of individuals with AAA and NA included in the study. Demographics and risk factors.
Measurements mRNA Secretion*
Characteristic AAA NA AAA NA
Number 39 15 30 12
Aortic diameter (mm) 70.4±13.9 - 67.5±13.7 -
Age (years) 71.7±7.8 58.4±13.9 71.7±8.1 59.1±15.2
Male 39 (100%) 7 (46.7%) 30 (100%) 6 (50%)
Diabetes mellitus 7 (17.9%) 2 (13.3%)a 5 (16.7%) 2 (16.7%)
Hypertension 26 (66.7%) 2 (13.3%)a 21(70%) 1 (8.3%)
Hyperlipidemia 22 (56.4%) 2 (13.3%)a 20 (66.7) 1 (8.3%)
Smokers 10 (25.6%) 3 (20%)a 9 (30%) 2 (16.7)
Coronary artery disease 10 (25.6%) 0a 10 (33.3%) 0a
Chronic renal insufﬁciency 21 (53.8%) 0a 18 (60%) 0a
Peripheral vascular disease 19 (48.7%) 0a 16 (53.3%) 0a
Cerebrovascular disease 4 (10.3%) 1 (6.7%)a 2 (6.7%) 1 (8.3%)
COPD 7 (17.9%) 0a 7 (23.3%) 0a
Antiplatelet users 22 (56.4%) 1 (6.7%)a 14 (46.7%) 1 (8.3%))
Statins users 24 (61.5%) 0a 18 (60%) 0a
IECAs users 11 (28.2%) 0a 7 23.3%) 0a
NSAID users 2 (5.1%) 0a 3 (10%) 0a
Corticoid users 2 (5.1%) 0a 2 (6.7%) 0a
Immuno-suppressors users 1 (2.6%) 0a 1 (3.3%) 0a
Nominal variables are presented as number and as percentage (%) and continuous variables as mean±SD. Abbreviations: Aortic diameter: aneurysm
maximum transverse diameter in mm. Chronic renal insufﬁciency: estimated glomerular ﬁltration rate (eGFR) 60 mL/min/1.73 m2. Smokers: smoking in
the last year. COPD: chronic obstructive pulmonary disease. Secretion*: prostanoid secretion by NA and AAA samples.
a In some cases due to the nature of NA samples some of the clinical characteristics are not always recorded and infra-evaluation of them is probable.
doi:10.1371/journal.pone.0136201.t001
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In an attempt to approach the relative contribution of the endothelium to PGE2 production
and degradation in AAA, we determined the statistical association of PGE2 levels with other
cell-characteristic prostanoids secreted by AAA samples as independent variables. We evalu-
ated PGE2, PGE2 metabolites (MPGE2) and 6-oxo-PGF1α, the stable metabolite of PGI2, which
is not produced by leukocytes. As Fig 3A shows, a significant positive correlation was found
between the production of PGE2 total and PGI2 (in terms of its stable metabolite) by AAA sam-
ples. We also observed a positive statistical association between levels of MPGE2 and PGI2 (Fig
3B). Nevertheless, the percentage of metabolized PGE2 showed a significant negative correla-
tion with the total amount of PGE2 (Fig 3C) and with PGI2 (Fig 3D),
Our results indirectly indicated that PGE2 production was associated with PGI2-producing
cells, and that degradation of PGE2 was negatively associated with the PGI2 production. We
therefore performed immunohistochemistry to locate 15-PGDH in AAA and NA samples. Fig
4A show examples of the 15-PGDH immunostaining in NA and AAA samples. 15-PGDH pro-
tein was not found in NA samples and immunostaining in AAA samples was located in the
areas of leukocyte infiltration. Immunofluorescent double staining showed that 15-PGDH was
mainly associated with CD45-positive cells but also with cells expressing the macrophage
marker CD68 (Fig 4B). To ascertain whether infiltrating lymphocytes accounted for 15-PGDH
expression in AAA samples, we performed double immunofluorescence staining of the
15-PGDH and T-cell (CD3) and B-cell (CD20) markers. Results in Fig 4B show that 15-PGDH
co-localize with both lymphocyte markers.
Discussion
This study describes the expression of the 15-PGDH in human abdominal aortic aneurysm
(AAA) for the first time. We found that 15-PGDHmRNA in aortic biopsies from AAA
patients was significantly increased compared with aortic biopsies from healthy donors and its
expression was mainly associated with infiltrating leukocytes. The MVEC COX-2/mPGES-1/
EP-4 axis is relevant for PGE2-mediated hypervascularization from the early stages of human
AAA development [16]. Here we confirmed our previous results [16] showing that expression
Fig 1. The expression of PGE2 biosynthetic and catabolic enzymes is increased in AAA. A, Box plot of expression levels of COX-2, mPGES-1 and
15-PGDH in controls (NA, n = 15) and abdominal aortic aneurysm (AAA, n = 39) samples; * p<0.05, when compared with NA samples.B, Box plot of the
percentage of metabolized PGE2 (MPGE2) in NA (n = 12) and AAA (n = 30) samples; * p<0.01, when compared with NA samples.
doi:10.1371/journal.pone.0136201.g001
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Fig 2. 15-PGDH expression is associated with leukocyte markers in AAA. A, Box plot of expression levels of cell markers in controls (NA, n = 15) and
abdominal aortic aneurysm (AAA, n = 39) samples; * p<0.05, *** p<0.001 when compared with NA samples.B Statistical correlations between transcript
levels of 15-PGDH and endothelial cell markers in AAA samples;C, statistical correlations between transcript levels of 15-PGDH and leukocyte markers in
AAA samples. Pearson Product Moment Correlation after logarithmic transformation of data and Bonferroni’s correction for multiple testing was applied;
(n = 39.)
doi:10.1371/journal.pone.0136201.g002
Fig 3. PGE2 production is associated with PGI2-producing cells. A, Statistical correlation between levels of 6-oxo-PGF1α and total PGE2 secreted by
AAA samples;B, statistical correlation between levels of 6-oxo-PGF1α and PGE2 metabolites (MPGE2) secreted by AAA samples.C, Statistical correlation
between the percentage of metabolized PGE2 secreted by AAA samples [%MPGE2; (MPGE2/totalPGE2)*100] and total PGE2; D, statistical correlation
between secreted levels of 6-oxo-PGF1α and%MPGE2. Pearson Product Moment Correlation after logarithmic transformation of data and Bonferroni’s
correction for multiple testing was applied; (n = 30).
doi:10.1371/journal.pone.0136201.g003
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Fig 4. 15-PGDH expression in AAA is mainly associated to CD45 cells. A, Representative immunohistochemistry images of 15-PGDH in NA and AAA
samples, arrows showmedial leukocyte immunostained with anti-15-PGDH; bars are 200μm (upper panels) and 50μm (lower panels).B, Representative
immunofluorescent double staining for 15-PGDH and leukocyte markers in leukocyte infiltration areas; arrows show double immunostained cells; M indicates
the light of microvessels; bars are 25μm.
doi:10.1371/journal.pone.0136201.g004
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of the PGE2-biosynthetic machinery, including COX isoenzymes and mPGES-1, is increased in
human AAA. Nevertheless, the PGE2 degradation rate also contributes to this activity.
15-PGDH is the first enzyme responsible for the biological inactivation of PGE2 [19–21]. Here
we found that 15-PGDH was upregulated in AAA, and consistently, the amount of MPGE2
secreted by AAA samples was higher than that secreted by NA. We previously reported that
when patients were stratified according to the aortic diameter, the transcript levels of endothe-
lial cell-markers and PGE2-biosynthetic enzymes were highest in the small diameter group
(<55mm), while transcript levels of leukocyte markers were highest in the moderate diameter
group (55–69.9mm) [16]. These observations led us to hypothesize that angiogenesis precedes
the maximum inflammatory response during AAA development. Identifying the role of micro-
vascular endothelium in PGE2-induced neovascularization in AAA, is a key question [2,23–
25]. We therefore need to clarify whether the enhanced expression of 15-PGDH and hence
PGE2 degradation occurs in microvessels or in the infiltrating immune cells.
In the present study, transcript levels of 15-PGDH were associated with the pan-leukocyte
marker CD45 and also with the macrophage marker CD68, but to a lesser extent. These results
indicate that 15-PGDH is associated not only with the macrophage population but also with
other infiltrating leukocytes.
We confirmed our previous results showing that expression of COX-2 and mPGES-1 were
increased in AAA [16]. COX-2 was found to be highly expressed in vascular cells and infiltrat-
ing leukocytes in AAA but weakly expressed in NA, suggesting that it was effectively up-regu-
lated in vascular cells, including MVEC. We also observed that mPGES-1 was increased in
AAA but the increase of mPGES-1 expression was not as high as that of COX-2 [16]. mPGES-
1 immunoreactivity was located in all vascular cells including VSMC in both NA and AAA. In
our previous work we proposed that a factor that could explain the modest increase of
mPGES-1 found in AAA could be the breakdown of VSMC in AAA. Indeed, VSMC abun-
dantly express mPGES-1 [10,11]. Our previous data indicated that both vascular cells and leu-
kocytes potentially contribute to PGE2 biosynthesis [16]. The contribution of the different cell
types present in aneurysmatic tissue to the PGE2 pool cannot be evaluated directly without
seriously modifying tissue samples. In this work, we therefore used an indirect strategy to
approach this matter. PGI-synthase is expressed in vascular cells—mainly in the endothelium
—but not in leukocytes. We observed an excellent positive statistical association between the
total secretion of PGE2 and PGI2 (in terms of 6-oxo-PGF1α) in aorta samples from AAA
patients. This indicates that the biosynthesis of PGE2 in AAA would be associated with the
cells producing PGI2 suggesting that MVEC contribute strongly to PGE2 biosynthesis in the
AAA wall. Nevertheless, this circumstantial evidence should be corroborated by further stud-
ies. When we tested the statistical association between the percentage of metabolized PGE2 and
total production of PGE2 we observed a negative significant correlation. As expected, similar
results were obtained when we analyzed the association between levels of PGI2 and the percent-
age of metabolized PGE2 secreted to the incubation media. Moreover, we did not find
15-PGDH expression in terms of mRNA, either in MVEC or in aortic VSMC in culture (data
not show). Altogether these results are consistent with the idea that PGE2 synthesized by the
vascular endothelium is not inactivated in situ.
To confirm that 15-PGDH was mainly expressed in infiltrating leukocytes we performed
immunohistochemistry and immunofluorescence studies. We did not observe 15-PGDH
immunostaining in NA samples but analysis of AAA samples showed 15-PGDH immunos-
taining, mainly in the perivascular areas where the density of infiltrating leukocytes was highest
[16]. The double immunofluorescence study showed coexpression of 15-PGDH with the leuko-
cyte marker CD45, and to a lesser extent with the macrophage marker CD68, reinforcing the
results obtained at mRNA level.
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The presence of mPGES-1 in a particular cell is necessary for PGE2 biosynthesis [9–
12,26,27]. In inflammatory diseases it is generally accepted that PGE2 comes from invading
leukocytes, mainly macrophages. Macrophage COX-2-derived PGE2 is relevant in the patho-
genesis and rupture of AAA [3,13–15]. Nevertheless, expression of 15-PGDH effectively regu-
lates active PGE2 present in a particular cell type. We previously reported that MVEC express
the PGE2 biosynthetic machinery [16,17]. We now add that 15-PGDH is expressed in leuko-
cytes, thereby causing greater inactivation of PGE2 in these cells than in MVEC. Hypervascu-
larization per se could be a determinant factor in reducing mechanical strength, because it
turns the media layer spongy and favors leukocyte-mediated matrix degradation. We have
shown that EP-4 activation, which is the main PGE-receptor in endothelial cells, induces
angiogenesis [16,28]. Accordingly, MVEC-derived PGE2 could play key role in the AAA-asso-
ciated hypervascularization since PGE2 could be more effective inducing angiogenesis in an
autocrine manner.
In conclusion, we found that 15-PGDH, the first enzyme involved in PGE2 inactivation, is
upregulated in AAA and its expression is mainly associated with infiltrating leukocytes. Con-
sidering that PGE2 plays a relevant role in angiogenesis, our results suggest that MVEC-derived
PGE2 acts in the AAA-associated hypervascularization in an autocrine manner and that
switching of endothelium to an inflammatory phenotype is a key point in AAA development.
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